ES2063060T3 - Benzamida contra enfermedades cognoscitivas. - Google Patents

Benzamida contra enfermedades cognoscitivas.

Info

Publication number
ES2063060T3
ES2063060T3 ES89100901T ES89100901T ES2063060T3 ES 2063060 T3 ES2063060 T3 ES 2063060T3 ES 89100901 T ES89100901 T ES 89100901T ES 89100901 T ES89100901 T ES 89100901T ES 2063060 T3 ES2063060 T3 ES 2063060T3
Authority
ES
Spain
Prior art keywords
cognoscitive
diseases
benzamide
benzamide against
morpholinoethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89100901T
Other languages
English (en)
Inventor
Roman Dr Amrein
Ravi Dr Anand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2063060T3 publication Critical patent/ES2063060T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PUEDE UTILIZAR P - CLORO - N (2 - MORFOIINOETIL) BENZAMIDA PARA ENFERMEDADES COGNITIVAS Y PUEDEN DESPUES POR TRATAMIENTO EN SU CASO PREVENIR ENFERMEDADES COGNITIVAS, PRINCIPALMENTE DE AQUELLAS, QUE SOBREVIENEN CON LA EDAD.
ES89100901T 1988-01-28 1989-01-19 Benzamida contra enfermedades cognoscitivas. Expired - Lifetime ES2063060T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH29888 1988-01-28

Publications (1)

Publication Number Publication Date
ES2063060T3 true ES2063060T3 (es) 1995-01-01

Family

ID=4183804

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89100901T Expired - Lifetime ES2063060T3 (es) 1988-01-28 1989-01-19 Benzamida contra enfermedades cognoscitivas.

Country Status (15)

Country Link
US (1) US4906626A (es)
EP (1) EP0326023B1 (es)
JP (1) JPH07116043B2 (es)
KR (1) KR960016203B1 (es)
AT (1) ATE113207T1 (es)
AU (1) AU620584B2 (es)
CA (1) CA1332151C (es)
DE (1) DE58908544D1 (es)
DK (1) DK171094B1 (es)
ES (1) ES2063060T3 (es)
HU (1) HU203042B (es)
IE (1) IE65409B1 (es)
IL (1) IL89031A (es)
PH (1) PH26030A (es)
ZA (1) ZA89523B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE124865T1 (de) * 1986-12-17 1995-07-15 Glaxo Group Ltd Verwendung von heterocyclischen verbindungen zur behandlung von bewusstseinsstörungen.
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
JP3172202B2 (ja) * 1990-11-29 2001-06-04 エフ．ホフマン−ラ ロシュ アーゲー 不安の障害の処置剤
US6951884B2 (en) * 2002-06-12 2005-10-04 Hoffmann-La Roche Inc. Fluorobenzamides and uses thereof
AU2004283452A1 (en) * 2003-10-23 2005-05-06 F. Hoffmann-La Roche Ag Benzazepine derivatives as MAO-B inhibitors
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
US8173642B2 (en) 2005-10-25 2012-05-08 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives
RU2476430C2 (ru) 2007-04-24 2013-02-27 Сионоги Энд Ко., Лтд. Производные аминодигидротиазина, замещенные циклической группой
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP2305672B1 (en) 2008-06-13 2019-03-27 Shionogi & Co., Ltd. SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY
EP2360155A4 (en) * 2008-10-22 2012-06-20 Shionogi & Co 2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
JPWO2011071135A1 (ja) 2009-12-11 2013-04-22 塩野義製薬株式会社 オキサジン誘導体
WO2012057247A1 (ja) 2010-10-29 2012-05-03 塩野義製薬株式会社 縮合アミノジヒドロピリミジン誘導体
WO2012057248A1 (ja) 2010-10-29 2012-05-03 塩野義製薬株式会社 ナフチリジン誘導体
TW201247635A (en) 2011-04-26 2012-12-01 Shionogi & Co Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them
WO2014065434A1 (en) 2012-10-24 2014-05-01 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
US10599006B2 (en) 2016-04-12 2020-03-24 E-Vision Smart Optics, Inc. Electro-active lenses with raised resistive bridges
WO2017180184A1 (en) 2016-04-12 2017-10-19 E-Vision Smart Optics, Inc. Electro-active lenses with raised resistive bridges

Also Published As

Publication number Publication date
DK171094B1 (da) 1996-06-03
DE58908544D1 (de) 1994-12-01
DK36889A (da) 1989-07-29
KR960016203B1 (ko) 1996-12-06
US4906626A (en) 1990-03-06
DK36889D0 (da) 1989-01-27
HU203042B (en) 1991-05-28
CA1332151C (en) 1994-09-27
EP0326023B1 (de) 1994-10-26
KR890011589A (ko) 1989-08-21
JPH01224318A (ja) 1989-09-07
EP0326023A3 (en) 1990-09-05
ATE113207T1 (de) 1994-11-15
IE890273L (en) 1989-07-28
IL89031A0 (en) 1989-08-15
AU2883689A (en) 1989-08-03
PH26030A (en) 1992-01-29
EP0326023A2 (de) 1989-08-02
JPH07116043B2 (ja) 1995-12-13
IE65409B1 (en) 1995-10-18
ZA89523B (en) 1989-09-27
HUT50042A (en) 1989-12-28
AU620584B2 (en) 1992-02-20
IL89031A (en) 1995-07-31

Similar Documents

Publication Publication Date Title
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
ATE79761T1 (de) Behandlung einer krankheit vom aids-typ.
NO950784L (no) Fettsyrederivater
DE3781182D1 (de) Tamoxifen zur topischen verwendung.
FI864570A0 (fi) Terapeutiskt anvaendbar foerening.
KR930702019A (ko) 피부.각막 질환 치료제
EP0305890A3 (en) Use of bezafibrate for the treatment of diabetes
ATE116850T1 (de) Mittel zur behandlung von erkrankungen der venen und des analbereichs.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
DE59010504D1 (de) Typisierung humaner Rhinoviren
GR80629B (en) Pharmacologically active diarylindane -1,3-diones
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
ATE22010T1 (de) Antipsychotische trans-dihydrolisuride.
DE3684825D1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
DE68906028T2 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE79759T1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 326023

Country of ref document: ES